Mindfulness an effective treatment for episodic migraine Hina Zahid4 April 2020 7:45 AM GMTEnhanced mindfulness-based stress reduction is an effective treatment option for episodic migraine.
Magnet based noninvasive TNT shows promise in fecal incontinence Dr. Kamal Kant Kohli1 April 2020 7:30 AM GMTAUGUSTA, Ga.-Researchers at Medical College of Georgia and Augusta University Health System as well as Harvard University's Massachusetts General...
Prolonged exposure to Air pollution linked to dementia Dr. Kamal Kant Kohli31 March 2020 11:35 AM GMTResearchers at Karolinska Institutet have found that people continuously exposed to air pollution are at increased risk of dementia, especially if...
A new way to study HIV's impact on cognitive health Hina Zahid30 March 2020 2:30 PM GMTHalf of HIV patients have HIV-associated neurocognitive disorders (HAND), which can manifest in a variety of ways, from forgetfulness and confusion to ...
Brain exercises may curb cognitive impairment Hina Zahid30 March 2020 1:15 PM GMTExercises aimed at improving vision-based speed of processing (VSOP) and other brain functions may slow the progress of mild cognitive impairment,...
Low dose aspirin a day does not prevent dementia, finds study Hina Zahid29 March 2020 10:15 AM GMTMINNEAPOLIS - Daily low-dose aspirin intake does not reduce the risk of thinking and memory problems caused by mild cognitive impairment or probable...
EMA grants marketing authorisation for Cenobamate for treating Focal Seizures in Adults Dr. Kamal Kant Kohli27 March 2020 1:15 PM GMTPANGYO - European Medicines Agency (EMA) has accepted Arvelle Therapeutics' Marketing Authorization Application (MAA) for cenobamate, an anti-epileptic...
New drug receives Orphan Drug Designation for Phenylketonuria treatment from FDA Dr. Kamal Kant Kohli27 March 2020 11:45 AM GMTBALERNA - The US Food and Drug Administration (the 'FDA') has granted Orphan Drug Designation for the Company's drug candidate APR-OD031 for the treatm...
Zilucoplan found effective in generalized myasthenia gravis in JAMA study Dr. Kamal Kant Kohli27 March 2020 5:15 AM GMTThe findings of a phase 2 study.published in JAMA Neurology support a potential therapeutic role for zilucoplan in generalized myasthenia gravis .
FDA approves Zeposia for relapsing forms of multiple sclerosis in adults Dr. Kamal Kant Kohli27 March 2020 1:00 AM GMTThe U.S. Food and Drug Administration (FDA) has approved Zeposia (ozanimod) oral medication to treat adults with relapsing forms of multiple sclerosis ...
Mother to infant close contact improves cognition in premature kids Dr. Kamal Kant Kohli26 March 2020 3:15 PM GMTAs the world prioritizes social distancing to stop or slow down the spread of coronavirus (COVID-19), there are certain situations where close contact ...
Autoantibodies in the brain may trigger epilepsy Hina Zahid26 March 2020 12:15 PM GMTResearchers have now identified an autoantibody that is believed to be responsible for encephalitis in some patients.
